GlassScriptPhysician profile
Jennifer Paruch
NPI 1770805871
$62,505.57
in general payments reported to CMS, 2019-2025
19 companies · $26K in 2025
The $26K reported for 2025 was more than what 96% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,742 · 2020: $9,128 · 2021: $354 · 2022: $1,041 · 2023: $4,919 · 2024: $16K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Consulting Fee: $14K · Travel and Lodging: $4,412 · Food and Beverage: $2,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,000.00 |
| Consulting Fee | $14,312.51 |
| Travel and Lodging | $4,411.78 |
| Food and Beverage | $2,516.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $45,349.44 | 2023-2025 | Gelport Laparoscopic System |
| Intuitive Surgical, INC. | $13,116.58 | 2019-2024 | |
| Ethicon US, LLC | $686.61 | 2019-2024 | Vistaseal, Ethicon |
| Medtronic, INC. | $635.16 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $554.95 | 2019-2020 | |
| Stryker Corporation | $443.56 | 2022 | |
| Axonics, INC. | $279.93 | 2023-2024 | Axonics |
| Boston Scientific Corporation | $264.08 | 2022-2024 | |
| Pentax of America, INC. | $242.68 | 2024 | Pentax Medical, C2 Cryoballoon, Inspira |
| Baxter Healthcare | $202.91 | 2019-2022 | |
| Steris Corporation | $151.48 | 2025 | |
| Kerecis Limited | $139.01 | 2022 | |
| Erbe USA INC | $125.00 | 2021 | |
| Biom'Up Sa | $96.83 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $86.72 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $62.50 | 2025 | Hemoblast Bellows |
| Covidien LP | $54.81 | 2019 | |
| Daiichi Sankyo INC. | $13.32 | 2023 | Enhertu |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Paruch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.